Abstract:Background While substantial progress has been made in blocking acute transplant rejection with the advent of immune suppressive drugs, chronic rejection, mediated primarily by recipient antigen presentation, remains a formidable problem in clinical transplantation. We hypothesized that blocking co-stimulatory pathways in the recipient by induction of RNA interference using small interference RNA (siRNA) expression vectors can prolong allogeneic heart graft survival. Method Vectors expressing siRNA specifically targeting CD40 and CD80 were prepared. Recipients (BALB/c mice) were treated with CD40 and/or CD80 siRNA expression vectors via hydrodynamic injection. Control groups were injected with a scrambled siRNA vector and sham treatment (PBS). After treatment, a fully MHC-mismatched (BALB/c to C57/BL6) heart transplantation was performed. Result Allogeneic heart graft survival (>100 days) was approximately 70% in the mice treated simultaneously with CD40 and CD80 siRNA expression vectors with overall reduction in lymphocyte interstitium infiltration, vascular obstruction, and edema. Hearts transplanted into CD40 or CD80 siRNA vector-treated recipients had an increased graft survival time compared to negative control groups, but did not survive longer than 40 days. In contrast, allogenic hearts transplanted into recipients treated with scrambled siRNA vector and PBS stopped beating within 10–16 days. Real-time PCR (RT-PCR) and flow cytometric analysis showed an upregulation of FoxP3 expression in spleen lymphocytes and a concurrent downregulation of CD40 and CD80 expression in splenic dendritic cells of siRNA-treated mice. Functional suppressive activity of splenic dendritic cells (DCs) isolated from tolerant recipients was demonstrated in a mixed lymphocyte reaction (MLR). Furthermore, DCs isolated from CD40- and CD80-treated recipients promoted CD4 + CD25 + FoxP3+ regulatory T cell differentiation in vitro. Conclusion This study demonstrates that the simultaneous silencing of CD40 and CD80 genes has synergistic effects in preventing allograft rejection, and may therefore have therapeutic potential in clinical transplantation.

Knockdown of Interleukin-2 by Shrna-Mediated RNA Interference Prolongs Liver Allograft Survival

SHARP-2 Gene Silencing by Lentiviral-Based Short Hairpin RNA Interference Prolonged Rat Kidney Transplant Recipients' Survival Time.

SHARP-2 gene silence by lentiviral-based short hairpin RNA interference prolongs survival time of rat kidney transplant recipients

Induction of lymphocyte apoptosis in rat liver allograft by adenoviral gene transfection of human interleukin-10.

Gene Silencing of 4-1Bb by Rna Interference Inhibits Acute Rejection in Rats with Liver Transplantation

Recombinant Adenovirus Vector Ad-hIL-10 Protects Grafts from Cold Ischemia-Reperfusion Injury Following Orthotopic Liver Transplantation in Rats.

Cytoprotective effects of human interleukin-10 gene transfer against necrosis and apoptosis induced by hepatic cold ischemia/reperfusion injury.

Blockade of Inducible Costimulator Pathway to Prevent Acute Rejection in Rat Liver Transplantation

Prolonging rat liver allograft survival by blockade of OX40-OX40L co-stimulatory signaling

A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models

Increased Expression of Non-Interleukin-2 T Cell Growth Factors and Their Implications During Liver Allograft Rejection in Rats

Increased expression of non-interleukin-2 T cell growth factors and their implications during liver allograft rejection in rats.

Reduction of liver ischemia reperfusion injury by silencing of TNF-α gene with shRNA.

Synergic silencing of costimulatory molecules prevents cardiac allograft rejection

Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts.

Inhibition of Interferon Regulatory Factor 4 Attenuates Acute Liver Allograft Rejection in Mice

Effects of Combined Immune Therapy on Survival and Th1/Th2 Cytokine Balance in Rat Orthotopic Liver Transplantation

In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.

Inhibition of Myeloid Differentiation Factor 88 Signaling Mediated by Histidine-Grafted Poly(Beta-Amino Ester) Ester Nanovector Induces Donor-Specific Liver Allograft Tolerance

Augmenter of Liver Regeneration Attenuates Acute Rejection after Rat Liver Transplantation.

Induction of alloimmune tolerance in heart transplantation through gene silencing of TLR adaptors.